Intranasal murine model of Bordetella pertussis infection:: II.: Sequence variation and protection induced by a tricomponent acellular vaccine

被引:60
作者
Boursaux-Eude, C
Thiberge, S
Carletti, G
Guiso, N
机构
[1] Inst Pasteur, Lab Bordetella, F-75724 Paris 15, France
[2] SmithKline Beecham Biol, Rixensart, Belgium
关键词
Bordetella pertussis; murine model of protection; acellular vaccine;
D O I
10.1016/S0264-410X(99)00038-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
When pertussis toxin S1 subunit and pertactin structural genes in Bordetella pertussis clinical isolates from France and Germany were sequenced, 3 previously described S1 subunit types (S1 A, B and E), and 4 pertactin types (PRN A, B, C, A*) were found. PRN A*, present in the: WHO reference strain 18323, was not described previously. In a respiratory mouse model, a tricomponent acellular pertussis vaccine (Infanrix(TM)) was highly effective in promoting lung clearance of all isolates expressing different S1 subunit and pertactin suggesting that use of acellular vaccine will not increase the risks of pertussis infection by these B. pertussis variants. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2651 / 2660
页数:10
相关论文
共 25 条
  • [1] EVOLUTIONARY RELATIONSHIPS IN THE GENUS BORDETELLA
    ARICO, B
    GROSS, R
    SMIDA, J
    RAPPUOLI, R
    [J]. MOLECULAR MICROBIOLOGY, 1987, 1 (03) : 301 - 308
  • [2] Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination
    Baron, S
    Njamkepo, E
    Grimprel, E
    Begue, P
    Desenclos, JC
    Drucker, J
    Guiso, N
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (05) : 412 - 418
  • [3] Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type b conjugate vaccine or as pentavalent vaccine
    Begue, P
    Stagnara, J
    VieLeSage, F
    Bernard, JC
    Xerri, B
    Abitol, V
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (08) : 787 - 794
  • [4] MOLECULAR-CLONING AND CHARACTERIZATION OF PROTECTIVE OUTER-MEMBRANE PROTEIN-P.69 FROM BORDETELLA-PERTUSSIS
    CHARLES, IG
    DOUGAN, G
    PICKARD, D
    CHATFIELD, S
    SMITH, M
    NOVOTNY, P
    MORRISSEY, P
    FAIRWEATHER, NF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) : 3554 - 3558
  • [5] Pertussis in the Netherlands: An outbreak despite high levels of immunization with whole-cell vaccine
    deMelker, HE
    ConynvanSpaendonck, MAE
    Rumke, H
    vanWijngaarden, JK
    Mooi, FR
    Schellekens, JFP
    [J]. EMERGING INFECTIOUS DISEASES, 1997, 3 (02) : 175 - 178
  • [6] FINE PEM, 1987, REV INFECT DIS, V9, P866
  • [7] A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis
    Greco, D
    Salmaso, S
    Mastrantonio, P
    Giuliano, M
    Tozzi, AE
    Anemona, A
    Atti, MLCD
    Giammanco, A
    Panei, P
    Blackwelder, WC
    Klein, DL
    Wassilak, SGF
    Stefanelli, P
    Bottone, M
    Sofia, T
    Luzi, S
    Bellomi, G
    Cobianchi, F
    Canganella, G
    Meduri, F
    Scuderi, G
    Chiarini, A
    Maggio, M
    Taormina, S
    Genovese, M
    Moiraghi, A
    Barale, A
    DiTommaso, S
    Malaspina, S
    Vasile, E
    Ferraro, P
    DalLago, P
    DeMarzi, L
    Robino, L
    Giraldo, E
    Coppola, N
    Materassi, P
    Castellani, GT
    Basso, F
    Barbuti, S
    Quarto, M
    Lopalco, P
    DOrazio, P
    Sanguedolce, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) : 341 - 348
  • [8] GRIMPREL E, 1993, BIOLOGICALS, V21, P5
  • [9] GUISO N, 1998, INTRANASAL MURINE MO
  • [10] GUISO N, 1996, DEV BIOL STAND, V89, P193